From GlobeNewswire: 2024-06-04 16:05:00

Ocular Therapeutix, Inc. announced inducement awards for newly appointed Chief Medical Officer, Dr. Nadia K. Waheed, and six other employees. Dr. Waheed received a stock option for 425,000 shares and a restricted stock unit award for 141,666 shares. The other employees received stock options for 36,000 shares and restricted stock unit awards for 12,001 shares each. These inducement equity awards are subject to specific terms and conditions. Ocular Therapeutix is focused on developing therapies for eye diseases like wet age-related macular degeneration and diabetic retinopathy, with products like AXPAXLI™ and PAXTRAVA™ in clinical trials.



Read more at GlobeNewswire: Ocular Therapeutix® Reports Inducement Grants Under Nasdaq